Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Bufexamac MeSH Descriptor Data 2025


MeSH Heading
Bufexamac
Tree Number(s)
D02.065.064.294.088
D02.092.570.394.150
D02.241.511.372.150
D02.455.426.559.389.048.088
Unique ID
D002019
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D002019
Scope Note
A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
Entry Term(s)
Allergipuran
Bufal
Bufederm
Bufexamac-ratiopharm
Droxaryl
Jomax
Malipuran
Paraderm
Parfenac
Windol
duradermal
p-Butoxyphenylacethydroxamic Acid
Pharm Action
Anti-Inflammatory Agents, Non-Steroidal
Registry Numbers
4T3C38J78L
0
Related Numbers
2438-72-4
CAS Type 1 Name
Benzeneacetamide, 4-butoxy-N-hydroxy-
Previous Indexing
Hydroxamic Acids (1971-1974)
Phenylacetates (1971-1974)
Public MeSH Note
91; was see under HYDROXAMIC ACIDS 1975-90
History Note
91(75); was see under HYDROXAMIC ACIDS 1975-90
Date Established
1991/01/01
Date of Entry
1974/11/19
Revision Date
2016/07/05
Bufexamac Preferred
Droxaryl Narrower
Jomax Narrower
Malipuran Narrower
Windol Narrower
Allergipuran Narrower
Bufal Narrower
Bufederm Narrower
Bufexamac-ratiopharm Narrower
duradermal Narrower
page delivered in 0.145s